Health
Pharmaceutical
2017 IPO

OptiNose

249

$6.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-2.67%) As of 3:32 PM EST today
-$0.18 (-2.67%) Today

Why Robinhood?

You can buy or sell OptiNose and other stocks, options, ETFs, and crypto commission-free!

About OPTN

OptiNose, Inc. Common Stock, also called OptiNose, is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Read More Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

CEO
Peter Kaighn Miller
Employees
102
Headquarters
Yardley, Pennsylvania
Founded
2000
Market Cap
341.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
240.25K
High Today
$6.82
Low Today
$6.35
Open Price
$6.78
Volume
182.52K
52 Week High
$11.66
52 Week Low
$4.44

Collections

Health
Pharmaceutical
2017 IPO
US
North America

OPTN Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 5, After Hours

People Also Bought

TherapeuticsMD

13,707

$1.78

-3.78%

TherapeuticsMD

13,707

$1.78

-3.78%

iQIYI

31,747

$24.49

+2.13%

Corbus Pharmaceuticals

49,279

$5.26

+1.74%

Ford

389,090

$7.26

+0.41%

Sunrun

14,471

$20.71

-0.46%

GE

330,154

$10.94

-3.39%

HUYA

10,372

$19.73

+2.39%

Nektar Therapeutics

4,918

$21.33

-3.70%

NIO

130,241

$4.39

-0.23%

Viking Therapeutics

39,738

$6.25

-1.88%

Box

6,079

$14.90

-0.93%

Groupon

98,046

$1.41

-5.70%

You May Also Like

PM
GGM
CTSH
VISL
CMSC
OCC
SPYX
NERD
FCTR
SWDBY
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy OPTN

Market Price$6.55
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell OptiNose stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up